Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ANGPT2 gene

Known as: ANGIOPOIETIN 2, Ang2, ANGPT2 
This gene is involved in vascular remodeling.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
BACKGROUND Serum angiopoietin 2 levels have been associated with endothelial dysfunction and diabetic kidney disease… Expand
Is this relevant?
2020
2020
Abstract To date it is unknown if there is a predisposition to sepsis. In this respect, genetic studies have been conducted with… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2019
2019
Although mother-to-child transmission of HIV has dramatically declined, the number of in utero HIV-exposed, uninfected infants is… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
Review
2017
Review
2017
Available online 1 December 2016 Pericytes are a heterogeneous population of cells located in the blood vesselwall. Theywere… Expand
  • figure 1
  • figure 2
Is this relevant?
2016
2016
BackgroundUnresolved inflammation resulting in capillary leakage with endothelial barrier dysfunction is a major contributor to… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2016
2016
Endothelial dysfunction has been shown to be associated with severe complications and increased NRM after alloSCT. Endothelial… Expand
Is this relevant?
2015
2015
MicroRNAs are endogenously expressed small noncoding RNAs that regulate gene expression. Laminar blood flow induces… Expand
Is this relevant?
2015
2015
Platelet Endothelial Aggregation Receptor 1 (PEAR1) is a newly identified membrane protein reported to be involved in multiple… Expand
Is this relevant?
Highly Cited
2014
Highly Cited
2014
Angiopoietin-2 (Angpt2) plays a critical role in angiogenesis and tumour progression. Therapeutic targeting of Angpt2 has been… Expand
Is this relevant?
2011
2011
10508 Background: CALGB 80303 was a phase III trial of 602 patients (pts) with locally advanced or metastatic pancreatic cancer… Expand
Is this relevant?